Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Crossing Boundaries III forum on health systems research got off to an exciting start with a good number of guests in attendance. The two-day forum provided useful insights in ongoing research in low and middle income countries. Some of the topics discussed were on were on task shifting, interdisciplinary research methods, antimicrobial resistance, mental health and governance amongst others.

Attendees in a talk

The crossing boundaries III forum on health systems research at the Green Templeton College in Oxford, got off to an exciting start with a good number of guests in attendance. The two - day results dissemination and sharing forum provided useful insights and inputs in ongoing research in low and middle income countries. These studies have the potential impact of improving care for sick newborns and neonates and latest findings from the HSD-N research programme, identified current coverage and gaps in the care of newborns/neonatal services in Kenya.

The project is led by Professor Mike English and Dr Georgina Murphy via the KemriWellcome Trust in Nairobi and from their base at Nuffied Department of Medicine and the University of Oxford. Findings from this meeting focused on and the role of nursing in neonatal care provision, gaps in nursing numbers and potential solutions. Topics discussed were on task shifting, interdisciplinary research methods, antimicrobial resistance, mental health and governance amongst others. The two-day meeting was from the 4-5th of December 2017.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Peter Macharia wins RSTMH Emerging Leader Award

Peter Macharia is a spatial epidemiologist and a postdoc interested in disease mapping, healthcare access and mapping population vulnerabilities at KEMRI Wellcome. He received the RSTMH 2021 Emerging Leader Award, which recognises significant contributions in leadership, mentoring and capacity building in those who are early in their careers.

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

RECOVERY Trial paper on dexamethasone wins BMJ’s 2021 UK Research Paper of the Year Award

A RECOVERY Collaborative Group paper has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare. The paper, “Dexamethasone in Hospitalized Patients with Covid-19”, published in the New England Journal of Medicine, described the discovery in June 2020 of the world’s first effective, readily available treatment for COVID-19 – the inexpensive steroid, dexamethasone.

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.